Amedisys Inc. buy Royal Bank of Canada
Start price
16.04.25
/
50%
€79.50
Target price
16.04.26
€88.29
Performance (%)
6.92%
Price
14.08.25
€84.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 6.92%. This prediction currently runs until 16.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amedisys Inc. | - | - |
| iShares Core DAX® | 1.803% | 0.496% |
| iShares Nasdaq 100 | 0.429% | -0.410% |
| iShares Nikkei 225® | 0.708% | -3.799% |
| iShares S&P 500 | 0.288% | -0.218% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amedisys Inc. diskutieren
Amedisys, Inc. (NASDAQ: AMED) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.
Ratings data for AMED provided by MarketBeat